Pancreatic Carcinoma — Trials

Pancreatic Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,382 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 489
Recruiting: 282
Ph III recruiting: 29
Growth YoY: +27.7%
Industry share: 36%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (201)

clinicaltrialsPublishedShowing 151–154 of 154 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00039403	UCN-01 and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer	completed	Phase 1	30	National Cancer Institute (NCI)NIH	1	Jan 23, 2013	clinicaltrials
NCT00480584	A Phase I Trial of Capecitabine in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer	completed	Phase 1	20	H. Lee Moffitt Cancer Center and Research InstituteOTHER	1	Nov 8, 2012